Friday, October 22, 2021

New record reached in number of Covid-19 jabs per day

A total of 151,309 doses were administered yesterday alone.

Other News

The National Covid-19 Immunisation Programme (PICK) recorded its highest daily vaccination record since its implementation on Feb 24 with the administration of 151,309 doses yesterday.

According to the Covid-19 Vaccine Supply Access Guarantee Special Committee in a post on its Twitter account, yesterday’s recipients included 105,722 individuals who received a first jab.

“Meanwhile, another 45,587 received a second dose,” it said.

Health Minister Dr Adham Baba said in a Twitter post that as of yesterday, a total of 1,180,744 individuals in the country had completed both doses of Covid-19 vaccine.

He said a total of 2,609,377 individuals had received a first dose, bringing the total number of Covid-19 vaccine doses given in the country to 3,790,121 as of yesterday.

He said Selangor recorded the highest number of recipients who completed both doses of vaccine, at 152,215, followed by Sarawak (124,820), Kuala Lumpur (108,740), Perak (108,361) and Johor (107,192).

Yesterday, PICK coordinating minister Khairy Jamaluddin said the government was aiming to administer Covid-19 jabs to more than 200,000 people a day beginning next month, with the number to increase to over 300,000 a day in August.

As of yesterday, 52.7% or 12,774,132 individuals had registered for PICK, with Selangor recording the highest number of registrations at 3,367,090 people.

The second phase of PICK which runs from April to August will involve the vaccination of 9.4 million senior citizens as well as individuals from high-risk groups and those with disabilities.

The third phase, which began last month and will continue until February next year, involves individuals aged 18 and above, including non-citizens, with a target of at least 13.7 million people.

Under the first phase of the programme, held between February and April, about 500,000 frontliners, including health workers, were given the vaccine.

Follow us on Telegram for the latest updates:

Subscribe to our newsletter

To be updated with all the latest news and analyses.

Related Articles